Randox Biosciences : White Papers

Treat you better
Tuesday, June 07, 2022 Randox Laboratories is a world-leading IVD company that has been innovating in life sciences for over 35 years. With more than 130 patent families, its innovative products and...

Dementia in the DNA
Tuesday, June 07, 2022 Alzheimer’s disease is the most common cause of dementia, which currently affects over 46.8 million people across the world today. The ApoE4 varient of apoliprotein E (ApoE) is...

Biomarker multiplexing
Tuesday, June 07, 2022 Randox Laboratories is a global leader in healthcare diagnostics, with 5% of the world’s population receiving medical diagnosis using the company’s products every year. It...

The key to success in CDx
Thursday, April 06, 2017 Dr Claire Huguet of Randox Biosciences explains how precise antibody selection is enabling companion diagnostics (CDx) to drive the development of personalised medicine.

Your concept companion
Thursday, December 08, 2016 Companion diagnostics have been vital to the development of precision medicine, allowing prescriptions to be tailored to patients’ unique needs. Randox Biosciences explains why...

Companion diagnostics with a personal touch
Wednesday, January 27, 2016 The arrival of personalised medicine has enabled pharmaceutical companies to reinvent their business model. Clinical Trials Insight speaks to Dr Claire Huguet at Randox Biosciences...


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.